Emvision Medical Devices Ltd has released a press release.
EMV Technology to be Presented at Prestigious Conference
Filed with ASX ·
6ix hasn’t read this filing yet.
EMvision Medical Devices Ltd. on 6ix
Earlier from EMvision Medical Devices
- EMVision Receives $3.4m Non-Dilutive Funding this Quarter
- Notification regarding unquoted securities - EMV
- Clinical Trial Data Drives Confidence for Expanded Studies
- AGM Chairmans Address & Presentation
- AGM Chairman's Address & Presentation
Later from EMvision Medical Devices
- Application for quotation of securities - EMV
- S&P DJI Announces March 2022 Quarterly Rebalance
- New Appointments to Clinical Advisory Board
- EMVision Secures Strategic Agreement With Keysight
- Pause in Trading
Follow EMvision Medical Devices into a list and get an email when it puts out news.
Follow EMvision Medical Devices